UBS analyst Jon Windham downgrades Republic Services (NYSE:RSG) from Buy to Neutral.
Credit Suisse Initiates Coverage On Bio-Techne with Outperform Rating, Announces Price Target of $465
Credit Suisse analyst Dan Leonard initiates coverage on Bio-Techne (NASDAQ:TECH) with a Outperform rating and announces Price Target of $465.